In-line leukocyte depletion of thrombocyte apheresis concentrates

Infusionstherapie und Transfusionsmedizin

Volumn 26, Issue 5, 1999, Pages 288-292

  Zeiler, T ^a   Kretschmer, V ^b  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b NONE

Author keywords

Platelet filtration; Platelet function; Plateletpheresis; Platelets

Indexed keywords

ARTICLE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; LEUKOCYTE COUNT; LEUKOPENIA; PROTEIN EXPRESSION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTOPHERESIS;

EID: 0032870342     PISSN: 10198466     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053506     Document Type: Article

References (44)

1. Murphy MF: Platelet transfusions: The problem of refractoriness. Blood Rev 1990;4:16-24.
2. Eernisse JG, Brand A: Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components. Exp Hematol 1981;9:77-83.
3. Brand A, Claas FH, Voogt PJ, Wasser MN, Eernisse JG: Alloimmunization after leukocyte-depleted multiple random donor platelet transfusions. Vox Sang 1988;54:160-166.
4. Saarinen UM, Kekomaki R, Siimes MA, Myllyla G: Effective prophylaxis against platelet refractoriness in multitransfused patients by use of leukocyte-free blood components. Blood 1990;75:512-517.
5. Fisher M, Chapman JR, Ting A, Morris PJ: Alloimmunisation to HLA antigens following transfusion with leucocyte-poor and purified platelet suspensions. Vox Sang 1985;49:331-335.
6. Heddle NM: The efficacy of leukodepletion to improve platelet transfusion response: A critical appraisal of clinical studies. Transfus Med Rev 1994;8:15-28.
7. Lane TA, Anderson KC, Goodnough LT, Kurtz S, Moroff G, Pisciotto PT, Sayers, M, Silberstein LE: Leukocyte reduction in blood component therapy. Ann Intern Med 1992;117:151-162.
8. Reesink HW, Nydegger UE, Brand A, Pietersz RN, Andreu G. Gmur JP, Murphy S, Schiller CA, Kiehler TS: Should all platelet concentrates issued be leukocyte-poor? Vox Sang 1992;62:57-64.
9. Klein K: Standards for Blood Banks and Transfusion Services, ed 16. Bethesda, American Association of Blood Banks, 1994.
10. Andreu G, Dewailly J: Prevention of HLA alloimmunization by using leukocyte-depleted components. Curr Stud Hematol Blood Transfus 1994;60: 29-10.
11. Novotny VM, Witvliet M, Claas FH, Brand A: Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: A prospective study. Blood 1995;85:1736-1741.
12. Transformation of labile blood products: Deleukocytation. Journal Officiel de la Republique Francaise 1994;8:6738.
13. Gilbert GL, Hayes K, Hudson IL, James J: Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group. Lancet 1989;i:1228-1231.
14. Bowden RA, Slichter SJ, Sayers M, Weisdorf D, Cays M, Schoch G, Banaji M, Haake R, Welk K, Fisher L: A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995;86:3598-3603.
15. De WT, Schattenberg A, Van DB, Galama J, Olthuis H, Van-der MJ, Kunst VA: Prevention of primary cytomegalovirus infection after allogeneic bone marrow transplantation by using leukocytepoor random blood products from cytomegalovirus-unscreened blood-bank donors. Transplantation 1990;50:964-968.
16. Muylle L, Wouters E, Peetermans ME: Febrile reactions to platelet transfusion: The effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method. Transfusion 1996;36:886-890.
17. Aye MT, Palmer DS, Giulivi A, Hashemi S: Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion 1995;35:117-124.
18. Kretschmer V, Müller N, Godehardt E, Borberg H, Neumann HJ, Wesswange TG: German multicenter studies on plateletpheresis from healthy donors. German Hemapheresis Study Group. Int J Artif Organs 1993;16(suppl 5):125-129.
19. Richtlinien zur Blutgruppenbestimmung und Bluttransfusion (Hämotherapie). Köln, Deutscher Ärzte Verlag, 1996.
20. Kretschmer V, Rossa C: Optimizing cell separation with the Cell Separator AS-106; in Kretschmer V, Stangel W, Weißhaar D (Hrsg): Transfusionsmedizin 1990/91. Beitr Infusionsther. Basel, Karger 1991; vol 28, pp 188-194.
21. Moroff G, Eich J, Dabay M: Validation of use of the Nageotte hemocytometer to count low levels of white cells in white cell-reduced platelet components. Transfusion 1994;34:35-38.
22. Born GV: Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962;194:927-929.
23. Oksanen K, Ebeling F, Kekomaki R, Elonen E, Sahlstedt L, Volin L, Myllylae G: Adverse reactions to platelet transfusions are reduced by use of platelet concentrates derived from buffy coat. Vox Sang 1994;67:356-361.
24. Kirkley SA, Blumberg N: Use of single donor platelets. Blood Rev 1994;8:142-147.
25. Strassbourg Cedex: Guide to the Preparation, Use and Quality Assurance of Blood Components, ed 3. Strassbourg, Council of Europe Publishing, 1997.
26. Kao KJ, Mickel M, Braine HG, Davis K, Enright H, Gernsheimer T, Gillespie MJ, Kickler TS, Lee EJ, Mc Cullough JJ: White cell reduction in platelet concentrates and packed red cells by filtration: A multicenter clinical trial. The Trap Study Group. Transfusion 1995;35:13-19.
27. Moog R, Müller N, Kobke AC, Kalb R: Leukocyte filtration of single-donor platelet units through an integrated filter system for the Fresenius AS 104 blood cell separator. Vox Sang 1997;72:107-110.
28. Moog R, Valbonesi M, Carlier P, Müller N, Eisenbeisz F, Mitschulat H: Collection of platelets and peripheral progenitor cells with the Fresenius AS.TEC 204 Blood Cell Separator. J Clin Apheresis 1997;12:126-129.
29. Zeiler T, Kretschmer V, Zingsem J, Moog R, Eisenbeisz F: First experience with the new Cellseparator AS.TEC 204. Infusionsther Transfusionsmed 1995;22(suppl 2):54.
30. Mueller T, Schmidt S, Doescher A, Weiß H, Schunter F: Leuko-reduction using an integral sepacell filter early (4 h) or late (48 h, 120 h) after plateletpheresis does not affect platelet function; in Sibrowski W, Stangel W, Müller N (Hrsg): Transfusionsmedizin 1996/97. Beitr Infusionsther. Basel, Karger,. 1997; vol 34, pp 95-99.
31. Sweeney JD, Holme S, Stromberg RR, Heaton WA: In vitro and in vivo effects of prestorage filtration of apheresis platelets. Transfusion 1995;35: 125-130.
32. Holme S, Ross D, Heaton WA: In vitro and in vivo evaluation of platelet concentrates after cotton wool filtration. Vox Sang 1989;57:112-115.
33. Holme S, Snyder E, Heaton A, Keegan T, Napychank P: In vitro and in vivo evaluation of cotton wool filtration of platelet concentrates obtained by automated and manual apheresis. Transfusion 1992;32:328-333.
34. Brecher ME, Pineda AA, Zylstra HV, Chowdhury S, Forstrom LA: In vivo viability and functional integrity of filtered platelets. Transfusion 1990;30: 718-721.
35. Joustra DA, Boomgaard MN, Pietersz RN, Steneker I, de Korte D, Loos JA, Reesink HW: Effect of filtration on subsequently stored platelet concentrates. Vox Sang 1994;67:22-27.
36. The Trial to Prevent Alloimmunization to Platelets Study Group: Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 1997;337:1861-1869.
37. Pedigo M, Wun T, Paglieroni T: Removal by white cell-reduction filters of activated platelets expressing CD62. Transfusion 1993;33:930-935.
38. Triulzi DJ, Kickler TS, Braine HG: Detection and significance of alpha granule membrane protein 140 expression on platelets collected by apheresis. Transfusion 1992;32:529-533.
39. Holme S, Sweeney JD, Sawyer S, Elfath MD: The expression of p-selectin during collection, processing, and storage of platelet concentrates: Relationship to loss of in vivo viability. Transfusion 1997; 37:12-17.
40. Schooneman F, Claise C: The storage quality of apheresis platelets - Analysis of results from seven different cell separators. Transfus Sci 1996;17: 559-574.
41. Kretschmer V: Current trends in platelet transfusion - Transfusion practices in Europe. Infusionsther Transfusionsmed 1996;23(suppl 1):5-11.
42. Rock G, Figueredo A: Metabolic changes during platelet storage. Transfusion 1973;16:571-579.
43. Slichter SJ, Harker L: Preparation and storage of platelet concentrates. I. Factors influencing the harvest of viable platelets from whole blood. Br J Haematol 1976;34:395-402.
44. Filip D, Aster R: Relative hemostatic effectiveness of human platelets stored at 4°C and 22°C. J Lab Clin Med 1978;91:618-624.